| dc.contributor.author |
Hakariya, Hayase |
|
| dc.date.accessioned |
2026-06-15T07:30:16Z |
|
| dc.date.available |
2026-06-15T07:30:16Z |
|
| dc.date.issued |
2025 |
|
| dc.identifier.issn |
0167-6997 |
|
| dc.identifier.uri |
http://hdl.handle.net/10900/180776 |
|
| dc.language.iso |
en |
de_DE |
| dc.publisher |
Dordrecht : Springer |
de_DE |
| dc.relation.uri |
http://dx.doi.org/10.1007/s10637-025-01566-z |
de_DE |
| dc.subject.ddc |
610 |
de_DE |
| dc.title |
Addressing the drug development challenge for rare pediatric diseases in Japan: a case study of isotretinoin |
de_DE |
| dc.type |
Article |
de_DE |
| utue.quellen.id |
20251118000000_01413 |
|
| utue.publikation.seiten |
757-763 |
de_DE |
| utue.personen.roh |
Inoue, Shota |
|
| utue.personen.roh |
Ozaki, Akihiko |
|
| utue.personen.roh |
Hakariya, Hayase |
|
| utue.personen.roh |
Zhao, Jungang |
|
| utue.personen.roh |
Florez, Ivan D. |
|
| utue.personen.roh |
Morikawa, Yoshihiko |
|
| utue.personen.roh |
Tanimoto, Tetsuya |
|
| dcterms.isPartOf.ZSTitelID |
Investigational New Drugs |
de_DE |
| dcterms.isPartOf.ZS-Issue |
4 |
de_DE |
| dcterms.isPartOf.ZS-Volume |
43 |
de_DE |
| utue.fakultaet |
04 Medizinische Fakultät |
de_DE |
| utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |